Cervomed Announces Pharmacokinetic Results With New Neflamapimod Oral Tablet Formulation And Secures FDA Removal Of Drug Exposure Limit

(MENAFN - GlobeNewsWire - Nasdaq) New 50 mg tablet formulation delivers an improved pharmacokinetic profile and enables greater exposure and patient convenience FDA removal of the prior drug ...